Market Simplified Unlisted Shares
BUY
₹N/A
SELL
₹N/A
Market Simplified (MSIL) shares, like any stock, can experience a downtrend due to a variety of factors, including economic indicators, investor sentiment, and company-specific news. These factors can cause a decrease in demand, leading to a fall in share prices.
About Market Simplified Unlisted Shares
With over 15 years of industry experience, Market Simplified has developed a Digital Acceleration Solution powered by Experience Engineering. This innovative solution combines deep market knowledge, technological expertise, and the flexibility to adapt to client needs. The company is renowned for its award-winning team of consultants and development experts who deliver comprehensive end-to-end services, including creative software design, business analysis, prototyping, data visualization, quality assurance (QA) and testing, development, hosting, support, and maintenance.
Services Offered by Market Simplified:
- Solution Consulting
- UX Strategy & Design
- Interface Development
- Middleware Orchestration
- QA Automation & Security
- DevOps
- Innovation Augmentation
- Infrastructure & Monitoring Support
Product Portfolio:
- Shield – Smart Notification Engine
- MyFlow – Conversational AI & Workflow
- MSXtream – Streaming Engine
- MSDatalytics – Data Analytics
- MSXtend – Extension Solutions
Solutions Delivered by Market Simplified:
For Banks:
- Mobile Banking
- Conversational AI Platform (MyFlow)
- KYC Digital On-boarding
- Mobile Channel Management
- Platform Console
- User Experience Consulting
- User Management
For Brokerages & Wealth Management:
- Mobile & Web Trading
- Conversational AI Platform (MyFlow)
- Facebook Messenger Bot
- Community Chatbot
- Community Portal
- Shield – Alerts Engine
- KYC Digital On-boarding
- Symbol Search
- Option Chain
- Advanced Orders
- Create Your Index (CYI)
For Alternate Finance:
- Digital On-boarding
- Agricultural/ Farmer Loans
- Housing Loans
- Jewelry Loans
- SME Loans
- Invoice Factoring
Disclaimer*This research has been conducted on available data. Investors are advised to perform their own research and due diligence before making any investment decisions. We are not responsible for any financial losses or inaccuracies in the data provided
Pros
- Stock is trading at 1.14 times its book value
- Company is expected to give good quarter
- The company has been maintaining a healthy dividend payout of 26.3%
Cons
- Stock is trading at 1.14 times its book value
- Company is expected to give good quarter
- The company has been maintaining a healthy dividend payout of 26.3%
Key Details
Market Simplified Unlisted | ₹36 |
---|---|
Shares Price | |
Lot Size | |
52 Week High | |
52 Week LoW | |
Depository | |
PAN Number | |
ISIN Number | |
CIN | |
RTA |
Market Cap (in cr.) | ₹ 77 |
---|---|
P/E Ratio | |
P/B Ratio | |
Debt to Equity | |
ROE (%) | |
Book Value | |
EPS | |
Face Value | |
Total Shares |
Financials
P&L Statement | 2023 | 2022 |
---|---|---|
Revenue | 4832 | 4306 |
Cost of Material Consumed | 0 | 0 |
Gross Margins | 100 | 100 |
Change in Inventory | 0 | 0 |
Employee Benefit Expenses | 3435 | 2666 |
Other Expenses | 1131 | 1032 |
EBITDA | 266 | 608 |
OPM | 5.5 | 14.12 |
Other Income | 24 | 75 |
Finance Cost | 6 | 29 |
D&A | 138 | 272 |
EBIT | 128 | 336 |
EBIT Margins | 2.65 | 7.8 |
PBT | 146 | 382 |
PBT Margins | 3.02 | 8.87 |
Tax | -13 | 55 |
PAT | 159 | 327 |
NPM | 3.29 | 7.59 |
EPS | 0.74 | 1.97 |
Financial Ratios | FY23 | FY22 |
---|---|---|
Operating Margin | 3% | 9% |
Net Profit Margin | 3% | 6% |
Return on Equity | 4% | 11% |
Debt-Equity | 0 | 0.08 |
Current Ratio | 14.42 | 2.97 |
Dividend Payout | 0% | 0% |
Company | Themis Medicare Ltd | Sun Pharmaceutical Industries Ltd | Market Simplified |
---|---|---|---|
Market Cap (₹ Crores) | 2427 | 445808 | 91.97 |
Profitability Margin (%) | 12% | 20% | 3% |
ROCE (%) | 14% | 17% | 3% |
ROE (%) | 12% | 17% | 4% |
D/E Ratio | 0.25 | 0.05 | 0.03 |
P/E Ratio | 48.5 | 42.3 | 51.81 |
P/B Ratio | 6.39 | 7.11 | 2.05 |
Book Value per Share (₹) | 41 | 265 | 20.98 |
Assets | 2023 | 2022 |
---|---|---|
Fixed Assets | 261 | 220 |
CWIP | 726 | 481 |
Investments | 0 | 0 |
Trade Receivables | 278 | 449 |
Inventory | 0 | 0 |
Other Assets | 3768 | 2112 |
Total Assets | 5033 | 3262 |
Assets | 2023 | 2022 |
---|---|---|
Fixed Assets | 261 | 220 |
CWIP | 726 | 481 |
Investments | 0 | 0 |
Trade Receivables | 278 | 449 |
Inventory | 0 | 0 |
Other Assets | 3768 | 2112 |
Total Assets | 5033 | 3262 |